NFG
APTO

Noven Financial Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Noven Financial Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-41
Closed -$37K – 41
2019
Q1 		$37K Buy
41
+10
+32% +$9.05K 0.02% 36
2018
Q4 		$27K Buy
+31
New +$30.5K 0.03% 30

Other funds holding APTO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

Noven Financial Group's APTO Position: Q2 2019 in Review

Noven Financial Group sold out of Aptose Biosciences, Inc. (APTO) in Q2 2019, closing a stake of 41 shares — an estimated $37K sold.

Noven Financial Group first reported a position in APTO in Q4 2018 and held it in 2 quarters. The position peaked at $37K in Q1 2019. 30 funds tracked by Wall St. Rank hold APTO as of Q2 2019.

  • Noven Financial Group reported no remaining Aptose Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Noven Financial Group sold 41 Aptose Biosciences, Inc. shares in Q2 2019, an estimated $37K.
  • Noven Financial Group first reported a position in Aptose Biosciences, Inc. in Q4 2018 and held it in 2 quarters.
  • Noven Financial Group's Aptose Biosciences, Inc. position peaked at $37K in Q1 2019.
  • 30 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2019.

Based on Noven Financial Group's 13F filing for Q2 2019, filed 12 Aug 2019.